Nortech Systems Reports Q1 2026 Financial Results with Improved Metrics

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: May 13 2026

0mins

NSYS-8.74%

Explore Agentic TradingLet AI Trade for You

Source: Newsfilter

Significant Sales Growth: Nortech Systems reported net sales of $30.3 million in Q1 2026, a 12.7% increase from $26.9 million in Q1 2025, indicating strong demand in the medical imaging and device markets, which further solidifies its market position.
Dramatic Loss Reduction: The company recorded a net loss of only $34,000 in Q1 2026, a 97.4% decrease from a loss of $1.316 million in Q1 2025, reflecting significant improvements in cost control and operational efficiency, thereby enhancing investor confidence.
Positive EBITDA Turnaround: Adjusted EBITDA reached $350,000 compared to a negative $1 million in Q1 2025, marking a 135% improvement, which indicates ongoing enhancements in profitability and lays a solid foundation for future financial health.
Increased Backlog: As of March 31, 2026, the company reported a 90-day backlog of $31.5 million, up 18.5% from $26.7 million in the same period last year, providing strong support for performance growth in the second half of the year and reflecting sustained market demand.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy NSYS?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on NSYS

About NSYS

Nortech Systems, Inc. is a provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. The Company design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. It offers a full range of value-added engineering, technical and manufacturing services and support, including project management, designing, testing, prototyping, manufacturing, supply chain management and post-market services. Its manufacturing and engineering services include complex electromedical and electromechanical products, including medical devices, wire and cable assemblies, printed circuit board assemblies, complex higher-level assemblies and other box builds for a range of industries. The Company primarily serves original equipment manufacturers (OEMs) in the medical device, medical imaging, aerospace and defense, and industrial markets.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Nortech Systems Q1 2026 Earnings Call Highlights

May 15 2026seekingalpha

Significant Revenue Growth: In Q1 2026, Nortech Systems reported net sales of $30.3 million, a 41.2% year-over-year increase primarily driven by strong performance in aerospace and defense, showcasing the company's competitive edge and growth potential in key markets.
Operational Efficiency Improvement: Through strategic restructuring, Nortech achieved an operating income of $47,000 in Q1, while total operating expenses remained flat at $4.7 million, indicating positive progress in enhancing manufacturing efficiency and cost management.
Enhanced Order Visibility: As of May 31, 2026, Nortech's backlog increased to $90.8 million, reflecting a strong outlook in customer demand and production capacity, which is expected to drive future revenue growth.
Optimized Capital Structure: Nortech entered into agreements with Associated Bank for a $2.2 million term note and a $15 million asset-backed line of credit, which will lower borrowing costs and support future business growth, demonstrating the company's flexibility and foresight in financing.